Insulet manufactures the OmniPod insulin management system, a wearable automated insulin-delivery platform where disclosed vulnerabilities have centered on improper access control within the management system and its associated firmware. Treat this as a compact medical-device vendor profile; live severity, exploitation, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Insulet over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2020-10627HIGH Insulet Omnipod Insulin Management System insulin pump product ID 19191 and 40160 is designed to communicate using a wireless RF with an Insulet manufactured Personal Diabetes Mana | Dec 1, 2021 | 8.1 | 22 | NO | NO |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Insulet.
Media articles that mention a CVE ID that affects a product developed by Insulet — matched by CVE ID, not by vendor name.